-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Cytek Biosciences, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2020 to Q4 2024.
- Cytek Biosciences, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending December 31, 2024 was 131M shares, a 3.45% decline year-over-year.
- Cytek Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 131M shares, a 3.45% decline from 2023.
- Cytek Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 135M shares, a 2.37% decline from 2022.
- Cytek Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 139M shares, a 69.9% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)